Dissecting the tRNA Fragment tRF3E–Nucleolin Interaction: Implications in Breast Cancer
Biomolecules · 2025
DOI: 10.3390/biom15071054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Maurizio Falconi und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, RNA-Binding Proteins, Phosphoproteins, RNA, Transfer. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università di Camerino, University of Camerino, Fondazione Umberto Veronesi fellowship.
Abstract (Originalsprache)
Nucleolin (NCL), an RNA-binding protein which regulates critical cellular processes, is frequently dysregulated in human cancers, including breast cancer, making it an attractive therapeutic target. However, molecular details of the RNA-NCL interaction have not been investigated yet. A tRNA fragment named tRF3E, displaying tumor suppressor roles in breast cancer, was found to bind NCL with high affinity displacing NCL-controlled transcripts. Here, we investigated the determinants and cooperativity of tRF3E-NCL interaction by Electrophoretic Mobility Shift Assays and in silico docking analysis, using wild-type or mutated tRF3E. We found that NCL, through its RNA-binding domains (RBD1–2 and RBD3–4), binds simultaneously two tRF3E molecules, giving rise to an energetically favored complex. Instead, a mutant form of tRF3E (M19–24), in which the NCL recognition element in position 19–24 has been disrupted, contacts NCL exclusively at RBD3–4, causing the loss of cooperativity among RBDs. Importantly, when expressed in MCF7 breast cancer cells, tRF3E significantly reduced cell proliferation and colony formation, confirming its role as tumor suppressor, but tRF3E functional properties were lost when the 19–24 motif was mutated, suggesting that cooperativity among multiple domains is required for the NCL-mediated tRF3E antitumor function. This study sheds light on the dynamic of RNA-NCL interaction and lays the foundations for using tRF3E as a promising NCL-targeted biodrug candidate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy.
- Department of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy.
- School of Pharmacy, University of Camerino, 62032 Camerino, Italy.
- Department of Life and Environmental Sciences, Marche Polytechnic University, 60131 Ancona, Italy.
ORCID-Profile: Maurizio Falconi, Junbiao Wang, Andrea Costamagna, Massimo Bramucci, Michela Buccioni, Roberta Galeazzi, Cristina Marchini
Förderung
- Università di Camerino
- University of Camerino
- Fondazione Umberto Veronesi fellowship
Zitieren
APA
Falconi, M., Wang, J., Costamagna, A., Giangrossi, M., Alimi, S. S., Turco, E., Bramucci, M., Quassinti, L., Petrilli, R., Buccioni, M., Marucci, G., Amici, A., Defilippi, P., Galeazzi, R., & Marchini, C. (2025). Dissecting the tRNA Fragment tRF3E–Nucleolin Interaction: Implications in Breast Cancer. Biomolecules. https://doi.org/10.3390/biom15071054
Vancouver
Falconi M, Wang J, Costamagna A, Giangrossi M, Alimi SS, Turco E, et al. Dissecting the tRNA Fragment tRF3E–Nucleolin Interaction: Implications in Breast Cancer. Biomolecules. 2025. doi:10.3390/biom15071054
BibTeX
@article{Falconi2025,
author = {Falconi, Maurizio and Wang, Junbiao and Costamagna, Andrea and Giangrossi, Mara and Alimi, Sunday Segun and Turco, Emilia and Bramucci, Massimo and Quassinti, Luana and Petrilli, Rossana and Buccioni, Michela and Marucci, Gabriella and Amici, Augusto and Defilippi, Paola and Galeazzi, Roberta and Marchini, Cristina},
title = {Dissecting the tRNA Fragment tRF3E–Nucleolin Interaction: Implications in Breast Cancer},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15071054}
}
EUVIMED